Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
PHASE1
Total Enrollment
28 participants
Study Classification
INTERVENTIONAL
Study Start Date
2001-08-31
Study Completion Date
2003-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Microgravity during space flight induces physiological changes that affect astronauts' health and performance. Space flight simulations such as prolonged bed rest can mimic some of these changes and provide study conditions that are more accessible than during space flight. The European Space Agency, ESA together with the French national space agency, CNES and the Japanese national space agency, NASDA are performing extensive studies using long duration bed rest.
Previous studies including several long and short term bed rest campaigns have yielded significant medical data on the physiological changes induced by space flight. These data can be used to study the effect of countermeasures, methods helping to prevent these physiological changes.
The long duration bed rest, lasting 3 months undertakes a variety of investigations involving 28 subjects. This study focuses on countermeasures, studying the effect of a bone tissue stabilisation medication and resistive exercises to determine their suitability for use during long duration stays on ISS.
The physiological changes recorded during space flight and bed rest mimic those observed in some diseases and in the aging process. Significant clinical applications are expected as a direct result of this experiment and future equivalent studies.
Previous studies including several long and short term bed rest campaigns have yielded significant medical data on the physiological changes induced by space flight. These data can be used to study the effect of countermeasures, methods helping to prevent these physiological changes.
The long duration bed rest, lasting 3 months undertakes a variety of investigations involving 28 subjects. This study focuses on countermeasures, studying the effect of a bone tissue stabilisation medication and resistive exercises to determine their suitability for use during long duration stays on ISS.
The physiological changes recorded during space flight and bed rest mimic those observed in some diseases and in the aging process. Significant clinical applications are expected as a direct result of this experiment and future equivalent studies.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The spaceflights undertaken to date demonstrated that Man can adapt to the conditions existing in space, particularly to weightlessness. However, the space environment and the prevailing micro-gravity induce modifications which may affect the performances of the astronauts. These modifications concern in particular the cardiovascular and hormonal systems, the muscles, the bones, the blood and the immune system. Other problems may occur during long duration flights, such as the problems created by psychological stress due to the confinement, or those resulting from the cosmic rays (radiation).
In view of the fact that space flight opportunities are few, experiences simulating the effects of weightlessness experiences are undertaken on the earth, in order to better understand the adaptation mechanisms, prepare the spaceflights, perfect and evaluate corrective methods (called counter-measures) such as physical exercise or medication, to facilitate the astronauts' return to base. These experiments are also a necessity, in view of the difficulties encountered when carrying out certain experiences during the flights, due to the presence of too few astronauts on board, and to the lack of advanced biomedical devices onboard (scanner, etc.). The most common simulation is that of the anti-orthostatic bed rest (tilted position with the head slightly under the feet at a -6° angle).
Since the current objective is to simulate flights in the International Space Station (3 to 6 months) or possible flights to Mars (500 to 1000 days), it is mandatory to extend the duration of the simulation experiments. This is why three Space Agencies, CNES (France), European Space Agency (ESA, European Union), National Space Development Agency of Japan (NASDA, Japan) decided to join forces and undertake in common such simulation campaigns on ground, to best apprehend the adaptation processes to the constraints of the space environment.
The 2 main objectives of this experiment are:
* to study the physiological changes mechanisms during a ground-based experiment simulating long duration spaceflights,
* to develop and validate preventive methods (countermeasures) using standard tests.
This is why we will test in the present study the effects of an orthostatic bed rest (decubitus) of 90 days (3 months) on the following physiological systems :
* the bones,
* the muscles,
* the cardiovascular system and its control mechanisms,
* the sleep,
* the spine.
In the absence of gravity, the weight of the astronaut and that of the objects disappear completely. This induces modifications of the bones and the muscles which can severely affect the astronaut's life during the flight, and even more when returning to earth. This is a fundamental point to study, since it may become a limiting factor and even an obstacle to long duration flights. This experiment should also permit the test of physical exercise program and of a drug, pamidronate (AREDIA®), as counter-measures against the effects of weightlessness on the locomotion system (skeleton and muscles).
A total of 28 volunteers will participate to this experiment, split into three groups. Said experiment will spread on 2 years, 14 volunteers participating each time. The 3 groups are the following:
* Group "physical exercise" (9 volunteers),
* Group "drug" (pamidronate) (9 volunteers),
* Group "control" (10 volunteers).
Members of the groups will be drawn by lot among the participants
* Group "Exercise" : exposure of Man to microgravity results in a muscular atrophy which affects the muscles of the lumbar region and those of the lower limbs which are concerned by the standing position and the locomotion. During certain flights, physical exercise programs have been implemented, in order to fight against this muscular atrophy, maintain the physical condition required for the mission and prepare the astronauts for their return on earth. In the course of the present experiment, a physical exercise program will be tested on the 9 volunteers of this group (resistance training using both calf and knee extensor muscles with a special devicecalled Fly-Wheel).
* Group "Drug" : a Man in microgravity is the sole experimental model available to test the rapid occurrence of osteoporosis on a healthy subject. Osteoporosis, or porous bone, appears whenever the rate at which the bone material is replaced falls below that of resorption, thus creating a bone fragility and an increased risk of fracture (hip, spine and wrist essentially). It appears generally after menopause, when associated with aging and a lack of physical activity. The pamidronate (Aredia®) is a drug present on the market since many years, used for the treatment of several bone pathologies. This drug will be tested on the 9 volunteers of this group, to demonstrate its efficiency in treating of bone modifications. This drug (60mg) will be infused intravenously 14 days before bed rest.
* Group "control" : this group will serve as reference for the experimentation. Volunteers in this group will be without physical exercise and without drug. The existence of this group is necessary to be able to compare the results of the 2 types of counter-measures.
The experience will be carried out during a 120 days stay (a total of 4 months) at the Space Clinic and will comprise:
* 1 control ambulatory period of 15 days (subjects to report on day before) (-15 at -1),
* 1 anti-orthostatic (-6°) bed rest period of 90 days (1 at 90),
* 1 recovery ambulatory period of 15 days (subjects to depart the following morning) (+1 at +15), representing a total of 122 nights spent at the clinic for all volunteers.
The assessments will be done by different European and Japanese scientific teams,each one specialising in a specific domain. None of the 3 groups of volunteers will be submitted to all experimentation programs.
In view of the fact that space flight opportunities are few, experiences simulating the effects of weightlessness experiences are undertaken on the earth, in order to better understand the adaptation mechanisms, prepare the spaceflights, perfect and evaluate corrective methods (called counter-measures) such as physical exercise or medication, to facilitate the astronauts' return to base. These experiments are also a necessity, in view of the difficulties encountered when carrying out certain experiences during the flights, due to the presence of too few astronauts on board, and to the lack of advanced biomedical devices onboard (scanner, etc.). The most common simulation is that of the anti-orthostatic bed rest (tilted position with the head slightly under the feet at a -6° angle).
Since the current objective is to simulate flights in the International Space Station (3 to 6 months) or possible flights to Mars (500 to 1000 days), it is mandatory to extend the duration of the simulation experiments. This is why three Space Agencies, CNES (France), European Space Agency (ESA, European Union), National Space Development Agency of Japan (NASDA, Japan) decided to join forces and undertake in common such simulation campaigns on ground, to best apprehend the adaptation processes to the constraints of the space environment.
The 2 main objectives of this experiment are:
* to study the physiological changes mechanisms during a ground-based experiment simulating long duration spaceflights,
* to develop and validate preventive methods (countermeasures) using standard tests.
This is why we will test in the present study the effects of an orthostatic bed rest (decubitus) of 90 days (3 months) on the following physiological systems :
* the bones,
* the muscles,
* the cardiovascular system and its control mechanisms,
* the sleep,
* the spine.
In the absence of gravity, the weight of the astronaut and that of the objects disappear completely. This induces modifications of the bones and the muscles which can severely affect the astronaut's life during the flight, and even more when returning to earth. This is a fundamental point to study, since it may become a limiting factor and even an obstacle to long duration flights. This experiment should also permit the test of physical exercise program and of a drug, pamidronate (AREDIA®), as counter-measures against the effects of weightlessness on the locomotion system (skeleton and muscles).
A total of 28 volunteers will participate to this experiment, split into three groups. Said experiment will spread on 2 years, 14 volunteers participating each time. The 3 groups are the following:
* Group "physical exercise" (9 volunteers),
* Group "drug" (pamidronate) (9 volunteers),
* Group "control" (10 volunteers).
Members of the groups will be drawn by lot among the participants
* Group "Exercise" : exposure of Man to microgravity results in a muscular atrophy which affects the muscles of the lumbar region and those of the lower limbs which are concerned by the standing position and the locomotion. During certain flights, physical exercise programs have been implemented, in order to fight against this muscular atrophy, maintain the physical condition required for the mission and prepare the astronauts for their return on earth. In the course of the present experiment, a physical exercise program will be tested on the 9 volunteers of this group (resistance training using both calf and knee extensor muscles with a special devicecalled Fly-Wheel).
* Group "Drug" : a Man in microgravity is the sole experimental model available to test the rapid occurrence of osteoporosis on a healthy subject. Osteoporosis, or porous bone, appears whenever the rate at which the bone material is replaced falls below that of resorption, thus creating a bone fragility and an increased risk of fracture (hip, spine and wrist essentially). It appears generally after menopause, when associated with aging and a lack of physical activity. The pamidronate (Aredia®) is a drug present on the market since many years, used for the treatment of several bone pathologies. This drug will be tested on the 9 volunteers of this group, to demonstrate its efficiency in treating of bone modifications. This drug (60mg) will be infused intravenously 14 days before bed rest.
* Group "control" : this group will serve as reference for the experimentation. Volunteers in this group will be without physical exercise and without drug. The existence of this group is necessary to be able to compare the results of the 2 types of counter-measures.
The experience will be carried out during a 120 days stay (a total of 4 months) at the Space Clinic and will comprise:
* 1 control ambulatory period of 15 days (subjects to report on day before) (-15 at -1),
* 1 anti-orthostatic (-6°) bed rest period of 90 days (1 at 90),
* 1 recovery ambulatory period of 15 days (subjects to depart the following morning) (+1 at +15), representing a total of 122 nights spent at the clinic for all volunteers.
The assessments will be done by different European and Japanese scientific teams,each one specialising in a specific domain. None of the 3 groups of volunteers will be submitted to all experimentation programs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Simulation of Weightlessness by Anti-Orthostatic Long Term Bed Rest
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
bedrest
spaceflight
Weightlessness
Countermeasure
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Primary Study Purpose
PREVENTION
Blinding Strategy
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ethidronate
Intervention Type
DRUG
Physical training
Intervention Type
BEHAVIORAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy male volunteer , citizen of the European Community.
* Age 25 to 45,
* Non smokers,
* No alcohol, no drug dependence and no medical treatment,
* Height 165 cm to 185 cm,
* No overweight nor excessive thinness. BMI (weight Kg/ height m2) between 20 and 27,
* No personal nor family past record of chronic or acute disease which could affect the physiological data and/or create a risk for the subject during the experiment,
* Subject to be covered by a Social Security system,
* Free of any engagement during four consecutive months.
* Age 25 to 45,
* Non smokers,
* No alcohol, no drug dependence and no medical treatment,
* Height 165 cm to 185 cm,
* No overweight nor excessive thinness. BMI (weight Kg/ height m2) between 20 and 27,
* No personal nor family past record of chronic or acute disease which could affect the physiological data and/or create a risk for the subject during the experiment,
* Subject to be covered by a Social Security system,
* Free of any engagement during four consecutive months.
Exclusion Criteria
* Having given blood (more than 300ml) in a period of three months or less before the start of the experiment,
* Subject already participating in a clinical research experimentation,
* Poor tolerance to blood sampling,
* Past record of orthostatic intolerance,
* Cardiac rhythm disorders,
* Allergies,
* Intensive sport training,
* Fractures or tendon laceration since less than one year,
* Chronic back pains,
* Past records of thrombophlebitis,
* Presence of metallic implants,
* Special food diet,
* Sleep disorders :Lark and owl type,Subject sleeping more than 10 hours or less than 5 hours,
* Photosensitive epilepsy.
* Subject already participating in a clinical research experimentation,
* Poor tolerance to blood sampling,
* Past record of orthostatic intolerance,
* Cardiac rhythm disorders,
* Allergies,
* Intensive sport training,
* Fractures or tendon laceration since less than one year,
* Chronic back pains,
* Past records of thrombophlebitis,
* Presence of metallic implants,
* Special food diet,
* Sleep disorders :Lark and owl type,Subject sleeping more than 10 hours or less than 5 hours,
* Photosensitive epilepsy.
Minimum Eligible Age
25 Years
Maximum Eligible Age
45 Years
Eligible Sex
MALE
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Space Agency
OTHER
Sponsor Role
collaborator
National Space Development Agency, Japan
OTHER
Sponsor Role
collaborator
Centre National d'Etudes Spatiales
OTHER_GOV
Sponsor Role
lead
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacques Bernard, Dr
Role: PRINCIPAL_INVESTIGATOR
MEDES - IMPS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medes-Imps
Toulouse, , France
Site Status
Countries
Review the countries where the study has at least one active or historical site.
France
References
Explore related publications, articles, or registry entries linked to this study.
Rittweger J, Frost HM, Schiessl H, Ohshima H, Alkner B, Tesch P, Felsenberg D. Muscle atrophy and bone loss after 90 days' bed rest and the effects of flywheel resistive exercise and pamidronate: results from the LTBR study. Bone. 2005 Jun;36(6):1019-29. doi: 10.1016/j.bone.2004.11.014. Epub 2005 Apr 2.
Reference Type
RESULT
Watanabe Y, Ohshima H, Mizuno K, Sekiguchi C, Fukunaga M, Kohri K, Rittweger J, Felsenberg D, Matsumoto T, Nakamura T. Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest. J Bone Miner Res. 2004 Nov;19(11):1771-8. doi: 10.1359/JBMR.040811. Epub 2004 Aug 23.
Reference Type
RESULT
Rittweger J, Felsenberg D. Patterns of bone loss in bed-ridden healthy young male subjects: results from the Long Term Bed Rest Study in Toulouse. J Musculoskelet Neuronal Interact. 2003 Dec;3(4):290-1; discussion 292-4. No abstract available.
Reference Type
RESULT
Gallagher P, Trappe S, Harber M, Creer A, Mazzetti S, Trappe T, Alkner B, Tesch P. Effects of 84-days of bedrest and resistance training on single muscle fibre myosin heavy chain distribution in human vastus lateralis and soleus muscles. Acta Physiol Scand. 2005 Sep;185(1):61-9. doi: 10.1111/j.1365-201X.2005.01457.x.
Reference Type
RESULT
Rudnick J, Puttmann B, Tesch PA, Alkner B, Schoser BG, Salanova M, Kirsch K, Gunga HC, Schiffl G, Luck G, Blottner D. Differential expression of nitric oxide synthases (NOS 1-3) in human skeletal muscle following exercise countermeasure during 12 weeks of bed rest. FASEB J. 2004 Aug;18(11):1228-30. doi: 10.1096/fj.03-0792fje. Epub 2004 Jun 4.
Reference Type
RESULT
Trappe S, Trappe T, Gallagher P, Harber M, Alkner B, Tesch P. Human single muscle fibre function with 84 day bed-rest and resistance exercise. J Physiol. 2004 Jun 1;557(Pt 2):501-13. doi: 10.1113/jphysiol.2004.062166. Epub 2004 Apr 2.
Reference Type
RESULT
Belin de Chantemele E, Pascaud L, Custaud MA, Capri A, Louisy F, Ferretti G, Gharib C, Arbeille P. Calf venous volume during stand-test after a 90-day bed-rest study with or without exercise countermeasure. J Physiol. 2004 Dec 1;561(Pt 2):611-22. doi: 10.1113/jphysiol.2004.069468. Epub 2004 Aug 26.
Reference Type
RESULT
Belin de Chantemele E, Blanc S, Pellet N, Duvareille M, Ferretti G, Gauquelin-Koch G, Gharib C, Custaud MA. Does resistance exercise prevent body fluid changes after a 90-day bed rest? Eur J Appl Physiol. 2004 Aug;92(4-5):555-64. doi: 10.1007/s00421-004-1121-6. Epub 2004 May 29.
Reference Type
RESULT
Reeves NJ, Maganaris CN, Ferretti G, Narici MV. Influence of simulated microgravity on human skeletal muscle architecture and function. J Gravit Physiol. 2002 Jul;9(1):P153-4.
Reference Type
RESULT
Belavy DL, Ohshima H, Rittweger J, Felsenberg D. High-intensity flywheel exercise and recovery of atrophy after 90 days bed--rest. BMJ Open Sport Exerc Med. 2017 Jul 24;3(1):e000196. doi: 10.1136/bmjsem-2016-000196. eCollection 2017.
Reference Type
DERIVED
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEDES/00-433
Identifier Type: -
Identifier Source: org_study_id